Scientific Program

2018/9/26 08:09

Time Day 1(28 November) Speaker
8:15-8:30 Opening Ceremony

8:30-9

Gene Therapy in Thalassemia

 

9-9:30

Regenerative Medicine Musculoskeletal Disorders

 

9:30-10

Regenerative Medicine Heart Disease

 

10-10:30

Updates in Treatment of Hemorrhagic Cystitis

 

10:30-11

Break

11-11:30

Tandem  ASCT in MM

 

11:30-12

Updates in Treatment of Acute GVHD

 

12-12:30

RIC in Hematologic Malignancies

 

12:30-13

MRD in Acute Leukemia

 

13-14

Lunch

14-14:30

Haploidentical HSCT in Non-Malignant Disorders

 

14:30-15

Updates in Treatment of Chronic GVHD

 

15-15:30

Updates in CMV Treatment

 

 

Time

Day 2(29 November)

Speaker

8:40-9:10

CAR-NK Cell Therapy in leukemia

 

9:10-9:40

KIR Donor Selection

 

9:40-10:10

Relapse of ALL Post-HSCT

 

10:10-10:30

Panel

 

10:30-11

Break

11-11:30

Immunotherapy Post-HSCT in HD

 

11:30-12

Immunotherapy Post-HSCT in acute leukemia

 

12-12:30

Relapse of AML Post-HSCT

 

12:30-13

Relapse of Lymphoma Post-HSCT

 

13-14

Lunch

14-14:30

Indications of Prophylaxis in MM Post-HSCT

 

14:30-15

XRT Post ASCT in Lymphoma

 

15-15:30

CNS XRT in ALL prior or post to HSCT